Abstract
Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Graphical Abstract
Current Nanomedicine
Title:Nanoceria: A Novel Cytoprotective Drug Delivery Carrier
Volume: 7 Issue: 2
Author(s): Jawahar Natarajan*Sukumar Nagavishwakya
Affiliation:
- JSS College of Pharmacy, JSS University, Mysore - Pharmaceutics Ootacamund, Tamil Nadu,India
Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Abstract: Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Export Options
About this article
Cite this article as:
Natarajan Jawahar*, Nagavishwakya Sukumar, Nanoceria: A Novel Cytoprotective Drug Delivery Carrier, Current Nanomedicine 2017; 7 (2) . https://dx.doi.org/10.2174/2468187307666170208104644
DOI https://dx.doi.org/10.2174/2468187307666170208104644 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: Translational Investigations for Chronic Pain)
Current Pharmaceutical Design Acrylamide Induced Toxicity and the Propensity of Phytochemicals in Amelioration: A Review
Central Nervous System Agents in Medicinal Chemistry The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders
Current Molecular Medicine Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design Preface:
CNS & Neurological Disorders - Drug Targets Rationale for Development of New Oral Anticoagulants
Cardiovascular & Hematological Disorders-Drug Targets A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury
Recent Patents on CNS Drug Discovery (Discontinued) Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates
Central Nervous System Agents in Medicinal Chemistry Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Gallic Acid Improved Amytryptiline Effect in Neuropathic Pain Induced by Partial Sciatic Nerve Ligation (PSNL) in Rats
The Natural Products Journal RNA Interference and Amyotrophic Lateral Sclerosis
Current Drug Metabolism Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Regulation of P2X3 Receptor Structure and Function
CNS & Neurological Disorders - Drug Targets Cancer and Treatment Modalities
Current Cancer Therapy Reviews Effect of <i>Umbelliprenin</i> on Antinociceptive Activity of Morphine in a Rat Model of Neuropathic Pain Induced by Chronic Constriction Injury of the Sciatic Nerve
The Natural Products Journal Ischemic and Oxidative Damage to the Hypothalamus May Be Responsible for Heat Stroke
Current Neuropharmacology Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents COX-2 Selectivity and Inflammatory Processes
Current Medicinal Chemistry